This company has been marked as potentially delisted and may not be actively trading.

Ritter Pharmaceuticals (RTTR) Competitors

RTTR vs. WHWK, CNTN, ANTX, MENS, and TTRX

Should you be buying Ritter Pharmaceuticals stock or one of its competitors? The main competitors of Ritter Pharmaceuticals include Whitehawk Therapeutics (WHWK), Hillstream Biopharma (CNTN), Anthem (ANTX), Jyong Biotech (MENS), and Turn Therapeutics (TTRX).

How does Ritter Pharmaceuticals compare to Whitehawk Therapeutics?

Ritter Pharmaceuticals (NASDAQ:RTTR) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

: 0.8% of Ritter Pharmaceuticals shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 15.4% of Ritter Pharmaceuticals shares are held by insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
: Ritter Pharmaceuticals has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500.
: In the previous week, Whitehawk Therapeutics had 2 more articles in the media than Ritter Pharmaceuticals. MarketBeat recorded 2 mentions for Whitehawk Therapeutics and 0 mentions for Ritter Pharmaceuticals. Whitehawk Therapeutics' average media sentiment score of 1.16 beat Ritter Pharmaceuticals' score of 0.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the news media.
Company Overall Sentiment
Ritter Pharmaceuticals Neutral
Whitehawk Therapeutics Positive
: Ritter Pharmaceuticals' return on equity of 0.00% beat Whitehawk Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Ritter Pharmaceuticals N/A N/A -162.05%
Whitehawk Therapeutics N/A -62.88% -58.98%
: Whitehawk Therapeutics has a consensus price target of $7.00, suggesting a potential upside of 66.27%. Given Whitehawk Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Whitehawk Therapeutics is more favorable than Ritter Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ritter Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Whitehawk Therapeutics
1 Sell rating(s)

1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.50
: Ritter Pharmaceuticals has higher earnings, but lower revenue than Whitehawk Therapeutics.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ritter Pharmaceuticals N/A N/A -$10.13M N/A N/A
Whitehawk Therapeutics $7.14M 29.15 -$20.60M $0.47 8.96

Company	Overall Sentiment
Ritter Pharmaceuticals	Neutral
Whitehawk Therapeutics	Positive

Company	Net Margins	Return on Equity	Return on Assets
Ritter Pharmaceuticals	N/A	N/A	-162.05%
Whitehawk Therapeutics	N/A	-62.88%	-58.98%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ritter Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Whitehawk Therapeutics	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ritter Pharmaceuticals	N/A	N/A	-$10.13M	N/A	N/A
Whitehawk Therapeutics	$7.14M	29.15	-$20.60M	$0.47	8.96

Summary

Whitehawk Therapeutics beats Ritter Pharmaceuticals on 10 of the 12 factors compared between the two stocks.

How does Ritter Pharmaceuticals compare to Hillstream Biopharma?

Ritter Pharmaceuticals (NASDAQ:RTTR) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

: 0.8% of Ritter Pharmaceuticals shares are held by institutional investors. Comparatively, 1.2% of Hillstream Biopharma shares are held by institutional investors. 15.4% of Ritter Pharmaceuticals shares are held by insiders. Comparatively, 6.7% of Hillstream Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: Ritter Pharmaceuticals has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Comparatively, Hillstream Biopharma has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500.
: In the previous week, Ritter Pharmaceuticals' average media sentiment score of 0.00 equaled Hillstream Biopharma'saverage media sentiment score.
Company Overall Sentiment
Ritter Pharmaceuticals Neutral
Hillstream Biopharma Neutral
: Ritter Pharmaceuticals' return on equity of 0.00% beat Hillstream Biopharma's return on equity.
Company Net Margins Return on Equity Return on Assets
Ritter Pharmaceuticals N/A N/A -162.05%
Hillstream Biopharma N/A -35.59% -27.05%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ritter Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Hillstream Biopharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ritter Pharmaceuticals N/A N/A -$10.13M N/A N/A
Hillstream Biopharma N/A N/A -$35.92M -$3.99 N/A

Company	Overall Sentiment
Ritter Pharmaceuticals	Neutral
Hillstream Biopharma	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Ritter Pharmaceuticals	N/A	N/A	-162.05%
Hillstream Biopharma	N/A	-35.59%	-27.05%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ritter Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ritter Pharmaceuticals	N/A	N/A	-$10.13M	N/A	N/A
Hillstream Biopharma	N/A	N/A	-$35.92M	-$3.99	N/A

Summary

Hillstream Biopharma beats Ritter Pharmaceuticals on 4 of the 7 factors compared between the two stocks.

How does Ritter Pharmaceuticals compare to Anthem?

Ritter Pharmaceuticals (NASDAQ:RTTR) and Anthem (NASDAQ:ANTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ritter Pharmaceuticals N/A N/A -$10.13M N/A N/A
Anthem N/A N/A -$35.17M -$1.16 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ritter Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Anthem
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Ritter Pharmaceuticals has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Comparatively, Anthem has a beta of -0.95, indicating that its share price is 195% less volatile than the S&P 500.
: 0.8% of Ritter Pharmaceuticals shares are held by institutional investors. Comparatively, 90.5% of Anthem shares are held by institutional investors. 15.4% of Ritter Pharmaceuticals shares are held by insiders. Comparatively, 20.8% of Anthem shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: In the previous week, Anthem had 6 more articles in the media than Ritter Pharmaceuticals. MarketBeat recorded 6 mentions for Anthem and 0 mentions for Ritter Pharmaceuticals. Ritter Pharmaceuticals' average media sentiment score of 0.00 equaled Anthem'saverage media sentiment score.
Company Overall Sentiment
Ritter Pharmaceuticals Neutral
Anthem Neutral
: Ritter Pharmaceuticals' return on equity of 0.00% beat Anthem's return on equity.
Company Net Margins Return on Equity Return on Assets
Ritter Pharmaceuticals N/A N/A -162.05%
Anthem N/A -55.04% -49.13%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ritter Pharmaceuticals	N/A	N/A	-$10.13M	N/A	N/A
Anthem	N/A	N/A	-$35.17M	-$1.16	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ritter Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Anthem	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Overall Sentiment
Ritter Pharmaceuticals	Neutral
Anthem	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Ritter Pharmaceuticals	N/A	N/A	-162.05%
Anthem	N/A	-55.04%	-49.13%

Summary

Anthem beats Ritter Pharmaceuticals on 5 of the 9 factors compared between the two stocks.

How does Ritter Pharmaceuticals compare to Jyong Biotech?

Jyong Biotech (NASDAQ:MENS) and Ritter Pharmaceuticals (NASDAQ:RTTR) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

: In the previous week, Jyong Biotech had 2 more articles in the media than Ritter Pharmaceuticals. MarketBeat recorded 2 mentions for Jyong Biotech and 0 mentions for Ritter Pharmaceuticals. Jyong Biotech's average media sentiment score of 0.00 equaled Ritter Pharmaceuticals'average media sentiment score.
Company Overall Sentiment
Jyong Biotech Neutral
Ritter Pharmaceuticals Neutral
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jyong Biotech N/A N/A N/A N/A N/A
Ritter Pharmaceuticals N/A N/A -$10.13M N/A N/A
: Company Net Margins Return on Equity Return on Assets
Jyong Biotech N/A N/A N/A
Ritter Pharmaceuticals N/A N/A -162.05%
: 0.8% of Ritter Pharmaceuticals shares are owned by institutional investors. 15.4% of Ritter Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jyong Biotech
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Ritter Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Overall Sentiment
Jyong Biotech	Neutral
Ritter Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jyong Biotech	N/A	N/A	N/A	N/A	N/A
Ritter Pharmaceuticals	N/A	N/A	-$10.13M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Jyong Biotech	N/A	N/A	N/A
Ritter Pharmaceuticals	N/A	N/A	-162.05%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jyong Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ritter Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Jyong Biotech beats Ritter Pharmaceuticals on 3 of the 5 factors compared between the two stocks.

How does Ritter Pharmaceuticals compare to Turn Therapeutics?

Turn Therapeutics (NASDAQ:TTRX) and Ritter Pharmaceuticals (NASDAQ:RTTR) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

: In the previous week, Turn Therapeutics' average media sentiment score of 0.00 equaled Ritter Pharmaceuticals'average media sentiment score.
Company Overall Sentiment
Turn Therapeutics Neutral
Ritter Pharmaceuticals Neutral
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Turn Therapeutics N/A N/A -$3.19M -$0.16 N/A
Ritter Pharmaceuticals N/A N/A -$10.13M N/A N/A
: Company Net Margins Return on Equity Return on Assets
Turn Therapeutics N/A N/A N/A
Ritter Pharmaceuticals N/A N/A -162.05%
: 0.8% of Ritter Pharmaceuticals shares are owned by institutional investors. 15.4% of Ritter Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: Turn Therapeutics presently has a consensus target price of $8.00, suggesting a potential upside of 116.22%. Given Turn Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Turn Therapeutics is more favorable than Ritter Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Turn Therapeutics
1 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Ritter Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Overall Sentiment
Turn Therapeutics	Neutral
Ritter Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Turn Therapeutics	N/A	N/A	-$3.19M	-$0.16	N/A
Ritter Pharmaceuticals	N/A	N/A	-$10.13M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Turn Therapeutics	N/A	N/A	N/A
Ritter Pharmaceuticals	N/A	N/A	-162.05%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Turn Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ritter Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Turn Therapeutics beats Ritter Pharmaceuticals on 5 of the 7 factors compared between the two stocks.

Get Ritter Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RTTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RTTR vs. The Competition

Export

Metric	Ritter Pharmaceuticals	Pharmaceutical Preparations Industry	Medical Sector	NASDAQ Exchange
Market Cap	$61.85M	$889.45M	$6.24B	$11.86B
Dividend Yield	N/A	4.84%	2.73%	5.21%
P/E Ratio	-2.09	1.71	29.04	28.48
Price / Sales	N/A	120.50	477.10	60.43
Price / Cash	N/A	20.07	27.62	36.52
Price / Book	13.40	7.60	9.67	6.67
Net Income	-$10.13M	-$4.80M	$3.55B	$332.64M

Ritter Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RTTR Ritter Pharmaceuticals	N/A	$1.34 +8.1%	N/A	N/A	$61.85M	N/A	N/A	7	Gap Up
WHWK Whitehawk Therapeutics	4.0714 of 5 stars	$4.01 -0.7%	$7.00 +74.6%	N/A	$190.68M	$7.15M	8.53	21
CNTN Hillstream Biopharma	0.0782 of 5 stars	$3.23 +3.5%	N/A	N/A	$176.77M	N/A	N/A	2
ANTX Anthem	0.1863 of 5 stars	$4.55 -2.8%	$2.00 -56.0%	N/A	$168.46M	N/A	N/A	N/A	Analyst Upgrade
MENS Jyong Biotech	N/A	$2.27 +4.1%	N/A	N/A	$165.74M	N/A	N/A	31

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RTTR) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ritter Pharmaceuticals (RTTR) Competitors

RTTR vs. WHWK, CNTN, ANTX, MENS, and TTRX

How does Ritter Pharmaceuticals compare to Whitehawk Therapeutics?

Summary

How does Ritter Pharmaceuticals compare to Hillstream Biopharma?

Summary

How does Ritter Pharmaceuticals compare to Anthem?

Summary

How does Ritter Pharmaceuticals compare to Jyong Biotech?

Summary

How does Ritter Pharmaceuticals compare to Turn Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RTTR vs. The Competition

Ritter Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ritter Pharmaceuticals (RTTR) Competitors

RTTR vs. WHWK, CNTN, ANTX, MENS, and TTRX

How does Ritter Pharmaceuticals compare to Whitehawk Therapeutics?

Summary

How does Ritter Pharmaceuticals compare to Hillstream Biopharma?

Summary

How does Ritter Pharmaceuticals compare to Anthem?

Summary

How does Ritter Pharmaceuticals compare to Jyong Biotech?

Summary

How does Ritter Pharmaceuticals compare to Turn Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RTTR vs. The Competition

Ritter Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools